Amarin Corporation Plc


Amarin Pops 4% After-Hours On Positive PCI Data For Vascepa

Shares in Amarin (AMRN) popped 4% in Thursday’s after hours trading after the company presented encouraging data on Vascepa (icosapent ethyl) in patients …

Amarin’s Vascepa To Take Part In Covid-19 Study In Adults With Heart Disease

Amarin announced on Friday that Kaiser Permanente Northern California (KPNC) is initiating a trial to study the potential of its lead product Vascepa to …

Amarin, Apotex Settle Vascepa Dispute; Analyst Stays Sidelined

Amarin (AMRN) has announced a settlement agreement with Apotex Inc. that resolves a patent litigation over Apotex’s abbreviated new drug application (ANDA) seeking …

Amarin Down 10% in Pre-Market On Generic Approval

Shares in Amarin (AMRN) are plunging 10% in Friday’s pre-market trading on the news that Hikma Pharmaceuticals (HKMPY) has received approval from the …

Amarin Reports Strong 1Q Vascepa Sales; Plans Patent Appeal For May

Biotech Amarin (AMRN) has announced strong preliminary 1Q20 sales of $150 million for its fish-oil derivative Vascepa, easily beating the consensus estimate of …

Judge’s Record Looks Unpromising for Amarin’s Appeal; Analyst Remains Bullish

It hasn’t been a good week for biotech Amarin (AMRN). On Monday, a District of Nevada judge ruled against the company and in favor of two generic drug makers seeking to establish their own versions of Amarin’s treatment for high triglycerides, Vascepa, …

Amarin Corporation plc (ADR) (AMRN) Announces 2Q:17 Financial Results; Shares Jump 9%

Amarin Corporation plc (NASDAQ:AMRN) announced financial results for the three and six months ended June 30, 2017, and provided an update on company operations. …

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Presented New Clinical and Pre-Clinical Data at American College of Cardiology Meeting

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced two posters presented yesterday at the annual meeting of the American College of Cardiology (ACC). This research adds to …

Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Reports Third Quarter 2015 Financial Results and Provides Update on Operations

Amarin Corporation plc (ADR) (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results …

Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR)’s New In Vitro Eicosapentaenoic Acid Study Data to Be Presented

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced the presentation of findings from a new in vitro study at the National Lipid Association Scientific Sessions being held …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts